Title of the document
I didn’t know anything about cancer before my diagnosis
but now I know a great deal.
Everyone’s cancer is different, and joining a clinical trial based on my HER2 biomarker was the
best course of treatment for mine.
Bruce Shipman
Diagnosis:
Biomarker:
Diagnosis and Early Treatment
The oncologist near my new home in Texas did not feel optimistic about standard treatment options. However, she had conducted several tests on my cancer, and transmitted a PET scan to MD Anderson Cancer Center that showed I was positive for the HER2 biomarker. That status qualified me for a clinical trial testing a promising drug called ZW25. At first, my appointment was scheduled for three weeks later, but waiting that long made me very nervous, and ultimately the medical team got me in the same week.
I had six months of chemotherapy starting in September 2021, and have been on ZW25 ever since. I go to Houston every two weeks, and the protocol includes giving blood, seeing the doctor and getting the ZW25 infusion. It takes about a day to do the whole thing. Quarterly, I do an echocardiogram and CAT scan and there has been no detection of cancer.
Doctors said they thought the condition had been progressing for four or five years.
The Case for Biomarker Testing
Meet other patients.
PDL-1 CLDN 18.2
Lauren Donithan
Lauren was diagnosed with Stage IV stomach cancer in 2023 at age 37.
HER2
Javier Flores
Javier received the grim diagnosis of Stage IV stomach cancer in 2017 at age 39.
MSI-high
Uroosa Khalid
HER2
Terri Brady
HER2
Bruce Shipman
In 2021, Bruce was in the midst of a cross-country move when he was diagnosed.
tumor
mutational
burden
Suzanne Ottinger